Phio Pharmaceuticals Corp. (PHIO) Company Sales Revenue

Corporate emblem and logo of Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals is building a foundation for long-term revenue through the licensing of RNA products. The company's annual sales volume on the GURU.Markets chart confirms the scaling trend, where the current mark is 0.00. However, expansion is complicated by patent battles within the nucleic acid niche. Development stability is ensured by retaining key scientists through a stock option system, minimizing the risk of talent migration to corporate behemoths.

Revenue and Sales Volume: RXi Pharmaceuticals (PHIO) for 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Phio Pharmaceuticals Corp (PHIO)

- price and consensus price forecast:
General company analysis:PHIO, RXi Pharmaceuticals
Signature product of Phio Pharmaceuticals Corp.

This indicator tracks the daily volume of cash inflows from product sales, reflecting the issuer's operational liquidity. By analyzing the revenue chart for Phio Pharmaceuticals (PHIO), an investor can promptly identify trend reversals and risks of price stagnation. This metric measures the intensity of capital inflows, which is critical for assessing financial stability during portfolio rebalancing. For Phio Pharmaceuticals (PHIO), this flow depends directly on the effectiveness of partnerships in the field of RNA interference and the development of immunotherapeutic drugs.

Competing companies

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|Company Sales Volume QURE (uniQure)|Company Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Sales Volume|Company Revenue Solid Biosciences SLDB|OCGN - Company Sales|pacb.com - Revenue and Sales Volume|Benitec (BNTC) - Company Sales|DSGN: Revenue and Sales Volume|RCKT - Company Gross Revenue|FDMT: Company Gross Revenue|Company Sales Volume LXEO (lexeotx.com)|Company Revenue Korro Bio Inc. (KRRO)|Company Total Sales EDIT|Revenue and Sales Volume SLN (Silence Therapeutics PLC)|Company Sales Revenue PRQR|CDXS - Company Revenue|SGMO (Sangamo Therapeutics) - Company Sales Volume|NAUT: Revenue and Sales Volume|Company Sales Volume MGX|DTIL (precisionbiosciences.com) - Revenue and Sales Volume|Company Sales Volume GBIO (Generation Bio Co.)|Company Revenue Boundless Bio (BOLD)|Exicure - Company Sales Volume|Revenue and Sales Volume IMNN (imunon.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales